Enze Jiashi Pharmaceutical

Beijing Enze Jiashi Pharmaceutical Technology is a clinical-stage biopharmaceutical company based in Beijing, China, dedicated to the discovery and development of innovative small molecule therapeutics. The company focuses on addressing significant unmet medical needs in oncology, metabolic diseases, and muscle-wasting conditions such as cancer cachexia and sarcopenia. Their lead candidate, EJ001, is a selective androgen receptor modulator (SARM) designed to increase muscle mass and improve physical function with a favorable safety profile. Supported by leading venture capital firms like HighLight Capital and Northern Light Venture Capital, Enze Jiashi continues to advance its proprietary pipeline through clinical development. The company aims to provide transformative treatments that enhance the quality of life for patients suffering from debilitating chronic diseases.